Invesco Ltd. Alkermes Plc. Transaction History
Invesco Ltd.
- $460 Billion
- Q2 2024
A detailed history of Invesco Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Invesco Ltd. holds 696,240 shares of ALKS stock, worth $19.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
696,240
Previous 600,303
15.98%
Holding current value
$19.2 Million
Previous $16.3 Million
3.26%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$801 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$551 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$395 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$303 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$254 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.52B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...